Article
Cancer drug resistance: an evolving paradigm.
Nature reviews. Cancer - 1 Oct 2013
Holohan Caitriona, Van Schaeybroeck Sandra, Longley Daniel B, Johnston Patrick G
Abstract excerpt
Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
